Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Fecal microbiota transplantation via colonoscopy for recurrent C. difficile Infection.

Allegretti JR, Korzenik JR, Hamilton MJ.

J Vis Exp. 2014 Dec 8;(94). doi: 10.3791/52154.

PMID:
25549239
2.

Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.

Langhorst J, Wulfert H, Lauche R, Klose P, Cramer H, Dobos GJ, Korzenik J.

J Crohns Colitis. 2015 Jan;9(1):86-106. doi: 10.1093/ecco-jcc/jju007. Epub 2014 Nov 28.

PMID:
25518050
3.

Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.

Juillerat P, Sokol H, Froehlich F, Yajnik V, Beaugerie L, Lucci M, Burnand B, Macpherson AJ, Cosnes J, Korzenik JR.

Inflamm Bowel Dis. 2015 Jan;21(1):60-70. doi: 10.1097/MIB.0000000000000225.

PMID:
25517594
4.

The Changing Epidemiology of Inflammatory Bowel Disease: Identifying New High-risk Populations.

de Silva P, Korzenik J.

Clin Gastroenterol Hepatol. 2015 Apr;13(4):690-2. doi: 10.1016/j.cgh.2014.11.022. Epub 2014 Nov 28. No abstract available.

PMID:
25451560
5.

Natural history of perianal Crohn's disease after fecal diversion.

Sauk J, Nguyen D, Yajnik V, Khalili H, Konijeti G, Hodin R, Bordeianou L, Shellito P, Sylla P, Korzenik J, Friedman S, Ananthakrishnan AN.

Inflamm Bowel Dis. 2014 Dec;20(12):2260-5. doi: 10.1097/MIB.0000000000000216.

PMID:
25230164
6.

Environmental triggers for IBD.

O'Toole A, Korzenik J.

Curr Gastroenterol Rep. 2014;16(7):396. doi: 10.1007/s11894-014-0396-y. Review.

PMID:
25048010
7.

Impaired innate immune function associated with fecal supernatant from Crohn's disease patients: insights into potential pathogenic role of the microbiome.

Meelu P, Marin R, Clish C, Zella G, Cox S, Yajnik V, Nguyen DD, Korzenik JR.

Inflamm Bowel Dis. 2014 Jul;20(7):1139-46. doi: 10.1097/MIB.0000000000000081.

PMID:
24892965
8.

SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease.

Fowler SA, Ananthakrishnan AN, Gardet A, Stevens CR, Korzenik JR, Sands BE, Daly MJ, Xavier RJ, Yajnik V.

J Crohns Colitis. 2014 Aug 1;8(8):845-51. doi: 10.1016/j.crohns.2014.01.003. Epub 2014 Jan 24.

PMID:
24461721
9.

Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts.

Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, Spiegelman D, Richter JM, Korzenik JR, Chan AT.

BMJ. 2013 Nov 14;347:f6633. doi: 10.1136/bmj.f6633.

10.

Marijuana use patterns among patients with inflammatory bowel disease.

Ravikoff Allegretti J, Courtwright A, Lucci M, Korzenik JR, Levine J.

Inflamm Bowel Dis. 2013 Dec;19(13):2809-14. doi: 10.1097/01.MIB.0000435851.94391.37.

11.

The accuracy of self-reported medical history: a preliminary analysis of the promise of internet-based research in Inflammatory Bowel Diseases.

Kelstrup AM, Juillerat P, Korzenik J.

J Crohns Colitis. 2014 May 1;8(5):349-56. doi: 10.1016/j.crohns.2013.09.012. Epub 2013 Oct 31.

PMID:
24183653
12.

Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals.

Juillerat P, Wasan SK, Fowler SA, Friedman S, Pabby VK, Coukas JA, Barto AE, Pellish R, Germansky KA, Cheifetz AS, Korzenik JR, Farraye FA, Yajnik V.

Inflamm Bowel Dis. 2013 Oct;19(11):2457-63. doi: 10.1097/MIB.0b013e3182a32a0d.

PMID:
23962896
13.

A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis.

Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT.

Gastroenterology. 2013 Nov;145(5):970-7. doi: 10.1053/j.gastro.2013.07.050. Epub 2013 Aug 2.

14.

Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease.

Knutson CG, Mangerich A, Zeng Y, Raczynski AR, Liberman RG, Kang P, Ye W, Prestwich EG, Lu K, Wishnok JS, Korzenik JR, Wogan GN, Fox JG, Dedon PC, Tannenbaum SR.

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):E2332-41. doi: 10.1073/pnas.1222669110. Epub 2013 Jun 10.

15.

Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.

Oxford EC, Nguyen DD, Sauk J, Korzenik JR, Yajnik V, Friedman S, Ananthakrishnan AN.

Am J Gastroenterol. 2013 Jul;108(7):1123-9. doi: 10.1038/ajg.2013.20. Epub 2013 Feb 19.

16.

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.

Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C.

Genome Biol. 2012 Apr 16;13(9):R79. doi: 10.1186/gb-2012-13-9-r79.

17.

Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease.

de Silva PS, Nguyen DD, Sauk J, Korzenik J, Yajnik V, Ananthakrishnan AN.

Aliment Pharmacol Ther. 2012 Sep;36(5):459-66. doi: 10.1111/j.1365-2036.2012.05214.x. Epub 2012 Jul 11.

PMID:
22784296
18.

Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease.

Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G, Ciulla D, Tabbaa D, Ingram J, Schauer DB, Ward DV, Korzenik JR, Xavier RJ, Bousvaros A, Alm EJ.

PLoS One. 2012;7(6):e39242. doi: 10.1371/journal.pone.0039242. Epub 2012 Jun 29.

19.

Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease.

Juillerat P, Schneeweiss S, Cook EF, Ananthakrishnan AN, Mogun H, Korzenik JR.

Aliment Pharmacol Ther. 2012 Aug;36(3):239-47. doi: 10.1111/j.1365-2036.2012.05173.x. Epub 2012 Jun 5.

PMID:
22670722
20.

Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.

Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, Ananthakrishnan AN.

Inflamm Bowel Dis. 2013 Feb;19(2):309-15. doi: 10.1002/ibd.23026.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk